Daniel Nebdal
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- Pancreatic and Hepatic Oncology Research 2
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Anne‐Lise Børresen‐Dale (7 shared papers)Ole Christian Lingjærde (6 shared papers)Åslaug Helland (7 shared papers)Hege Edvardsen (5 shared papers)Ann Rita Halvorsen (4 shared papers)Vessela N. Kristensen (4 shared papers)Jörg Tost (3 shared papers)Hiroko Kato Solvang (2 shared papers)
In The Last Decade
Daniel Nebdal
15 papers receiving 449 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 154
- Oncology 128
- Molecular Biology 205
- Radiology, Nuclear Medicine and Imaging 55
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Daniel Nebdal
This map shows the geographic impact of Daniel Nebdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Nebdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Nebdal more than expected).
Fields of papers citing papers by Daniel Nebdal
This network shows the impact of papers produced by Daniel Nebdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Nebdal. The network helps show where Daniel Nebdal may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Nebdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 109 | |
| 2 | 2018 | 79 | |
| 3 | 2019 | 51 | |
| 4 | 2013 | 45 | |
| 5 | 2019 | 40 | |
| 6 | 2018 | 36 | |
| 7 | 2014 | 29 | |
| 8 | 2016 | 17 | |
| 9 | 2021 | 11 | |
| 10 | 2019 | 11 | |
| 11 | 2013 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 0 |
About Daniel Nebdal
Daniel Nebdal is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 16 papers that have together received 453 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Endometrial and Cervical Cancer Treatments (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Cancer Research (154 citations), Oncology (128 citations), Molecular Biology (205 citations), Radiology, Nuclear Medicine and Imaging (55 citations) and Pulmonary and Respiratory Medicine (65 citations). Daniel Nebdal has collaborated with scholars based in Norway, France and Finland. Frequent co-authors include Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Åslaug Helland, Hege Edvardsen, Ann Rita Halvorsen, Vessela N. Kristensen, Jörg Tost, Hiroko Kato Solvang, Vessela N. Kristensen and Thomas Fleischer. Their work appears in journals such as Molecular Oncology, Acta Oncologica, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, International Journal of Cancer and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.